RO-415253

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRO-415253
Drug Alias NameRO-41-5253
ClassificationSmall molecules > Amino acid supplement, Lipids and VitaminsSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha antagonistsApoptosis stimulantsRetinoic acid receptors inhibitors
TargetsRetinoic acid receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A